[go: up one dir, main page]

DK2417262T3 - Nanopartikelmedieret tilførsel af sekvensspecifikke nukleaser - Google Patents

Nanopartikelmedieret tilførsel af sekvensspecifikke nukleaser

Info

Publication number
DK2417262T3
DK2417262T3 DK10714403.2T DK10714403T DK2417262T3 DK 2417262 T3 DK2417262 T3 DK 2417262T3 DK 10714403 T DK10714403 T DK 10714403T DK 2417262 T3 DK2417262 T3 DK 2417262T3
Authority
DK
Denmark
Prior art keywords
nanopartically
medicated
sequence
supply
specific nucleases
Prior art date
Application number
DK10714403.2T
Other languages
English (en)
Inventor
Jayakumar Samuel
Joseph Petolino
Steven Webb
Kerrm Yau
Narasimha Samboju
Original Assignee
Dow Agrosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Agrosciences Llc filed Critical Dow Agrosciences Llc
Application granted granted Critical
Publication of DK2417262T3 publication Critical patent/DK2417262T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8206Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by physical or chemical, i.e. non-biological, means, e.g. electroporation, PEG mediated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/14Enzymes or microbial cells immobilised on or in an inorganic carrier
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/04Plant cells or tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/21Endodeoxyribonucleases producing 5'-phosphomonoesters (3.1.21)
    • C12Y301/21004Type II site-specific deoxyribonuclease (3.1.21.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Peptides Or Proteins (AREA)
DK10714403.2T 2009-04-07 2010-04-07 Nanopartikelmedieret tilførsel af sekvensspecifikke nukleaser DK2417262T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16738909P 2009-04-07 2009-04-07
PCT/US2010/030155 WO2010118077A1 (en) 2009-04-07 2010-04-07 Nanoparticle mediated delivery of sequence specific nucleases

Publications (1)

Publication Number Publication Date
DK2417262T3 true DK2417262T3 (da) 2015-06-22

Family

ID=42173819

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10714403.2T DK2417262T3 (da) 2009-04-07 2010-04-07 Nanopartikelmedieret tilførsel af sekvensspecifikke nukleaser

Country Status (20)

Country Link
US (2) US9187755B2 (da)
EP (1) EP2417262B1 (da)
JP (3) JP5755636B2 (da)
KR (1) KR101701534B1 (da)
CN (1) CN102369287B (da)
AR (1) AR076225A1 (da)
AU (1) AU2010234539B2 (da)
BR (1) BRPI1015952B8 (da)
CA (1) CA2757831C (da)
DK (1) DK2417262T3 (da)
ES (1) ES2539327T3 (da)
HR (1) HRP20150564T1 (da)
HU (1) HUE026053T2 (da)
IL (1) IL214880A (da)
PT (1) PT2417262E (da)
RU (3) RU2612156C2 (da)
SI (1) SI2417262T1 (da)
TW (1) TWI576432B (da)
WO (1) WO2010118077A1 (da)
ZA (1) ZA201106262B (da)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9339539B2 (en) 2008-11-07 2016-05-17 Hidaca Limited Transfection with magnetic nanoparticles
WO2012161764A1 (en) * 2011-02-16 2012-11-29 Fox Daniel N Magnetic sorting of mammalian sperm having damaged membranes
US10030245B2 (en) 2011-03-23 2018-07-24 E I Du Pont De Nemours And Company Methods for producing a complex transgenic trait locus
EP2697379B1 (en) * 2011-03-23 2018-08-29 Dow AgroSciences LLC Quantum dot carrier peptide conjugates suitable for imaging and delivery applications in plants
CN102250944B (zh) * 2011-06-02 2012-10-31 南京林业大学 一种CdSe/ZnS量子点与植物细胞的共孵育方法
SG11201401658SA (en) * 2011-10-21 2014-07-30 Stemgenics Inc Functionalized nanoparticles for intracellular delivery of biologically active molecules
BR112014031891A2 (pt) 2012-06-19 2017-08-01 Univ Minnesota direcionamento genético nas plantas utilizando vírus de dna
BR112015013784A2 (pt) 2012-12-12 2017-07-11 Massachusetts Inst Technology aplicação, manipulação e otimização de sistemas, métodos e composições para manipulação de sequência e aplicações terapêuticas
WO2014093701A1 (en) 2012-12-12 2014-06-19 The Broad Institute, Inc. Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
CN105531372A (zh) 2013-06-14 2016-04-27 塞尔克蒂斯股份有限公司 植物中非转基因基因组编辑方法
EP3011033B1 (en) 2013-06-17 2020-02-19 The Broad Institute, Inc. Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof
DK3011031T3 (da) 2013-06-17 2020-12-21 Broad Inst Inc Fremføring og anvendelse af crispr-cas-systemerne, vektorer og sammensætninger til levermålretning og -terapi
EP3011030B1 (en) 2013-06-17 2023-11-08 The Broad Institute, Inc. Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation
CA3109801C (en) 2013-08-22 2024-01-09 Andrew Cigan Plant genome modification using guide rna/cas endonuclease systems and methods of use
US10526616B2 (en) 2013-09-23 2020-01-07 Rensselaer Polytechnic Institute Nanoparticle-mediated gene delivery, genomic editing and ligand-targeted modification in various cell populations
KR20160089530A (ko) 2013-12-12 2016-07-27 더 브로드 인스티튜트, 인코퍼레이티드 Hbv 및 바이러스 질병 및 질환을 위한 crispr­cas 시스템 및 조성물의 전달,용도 및 치료적 적용
WO2015089473A1 (en) 2013-12-12 2015-06-18 The Broad Institute Inc. Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation
WO2015089351A1 (en) 2013-12-12 2015-06-18 The Broad Institute Inc. Compositions and methods of use of crispr-cas systems in nucleotide repeat disorders
IL289736B2 (en) 2013-12-12 2025-09-01 Massachusetts Inst Technology Administration, use and therapeutic applications of CRISPR–Cas gene editing systems and gene editing preparations
WO2015089486A2 (en) 2013-12-12 2015-06-18 The Broad Institute Inc. Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems
JP6455912B2 (ja) * 2014-03-24 2019-01-23 国立研究開発法人産業技術総合研究所 人工ヌクレアーゼの細胞への導入方法
CN106687594A (zh) 2014-07-11 2017-05-17 纳幕尔杜邦公司 用于产生对草甘膦除草剂具有抗性的植物的组合物和方法
WO2016040030A1 (en) 2014-09-12 2016-03-17 E. I. Du Pont De Nemours And Company Generation of site-specific-integration sites for complex trait loci in corn and soybean, and methods of use
EP3985115A1 (en) 2014-12-12 2022-04-20 The Broad Institute, Inc. Protected guide rnas (pgrnas)
EP3702456A1 (en) 2014-12-24 2020-09-02 The Broad Institute, Inc. Crispr having or associated with destabilization domains
AU2016214301B2 (en) * 2015-02-06 2022-05-19 Cellectis Primary hematopoietic cells genetically engineered by slow release of nucleic acids using nanoparticles
JPWO2016143223A1 (ja) * 2015-03-09 2017-12-28 株式会社島津製作所 外部環境変化に対する耐性が向上した固定化プロテアーゼ
WO2016155482A1 (zh) * 2015-03-16 2016-10-06 中国科学院遗传与发育生物学研究所 一种利用非遗传物质对植物基因组进行定点改造的方法
US10450576B2 (en) 2015-03-27 2019-10-22 E I Du Pont De Nemours And Company Soybean U6 small nuclear RNA gene promoters and their use in constitutive expression of small RNA genes in plants
WO2016205759A1 (en) 2015-06-18 2016-12-22 The Broad Institute Inc. Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
TWI813532B (zh) 2015-06-18 2023-09-01 美商博得學院股份有限公司 降低脱靶效應的crispr酶突變
US10456452B2 (en) 2015-07-02 2019-10-29 Poseida Therapeutics, Inc. Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles
US20170000743A1 (en) * 2015-07-02 2017-01-05 Vindico NanoBio Technology Inc. Compositions and Methods for Delivery of Gene Editing Tools Using Polymeric Vesicles
CN109069527B (zh) * 2016-03-15 2022-05-03 北卡罗来纳州立大学 纳米颗粒、控释剂型和用于递送免疫治疗剂的方法
ES2865481T3 (es) * 2016-04-29 2021-10-15 Poseida Therapeutics Inc Micelas basadas en poli(histidina) para la complejación y el aporte de proteínas y ácidos nucleicos
CA3039924A1 (en) * 2016-10-11 2018-04-19 Stemgenics, Inc. Nanoparticles functionalized with gene editing tools and related methods
WO2018085693A1 (en) 2016-11-04 2018-05-11 Inari Agriculture, Inc. Novel plant cells, plants, and seeds
CA3045131A1 (en) 2016-12-14 2018-06-21 Ligandal, Inc. Methods and compositions for nucleic acid and protein payload delivery
EP3392339A1 (en) 2017-04-18 2018-10-24 Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen Improved genome editing in plant cells
RU2663347C1 (ru) * 2017-07-12 2018-08-03 Общество с ограниченной ответственностью "Дока-Генные Технологии" Способ доставки биологически активных макромолекул в клетки растений
US12084676B2 (en) 2018-02-23 2024-09-10 Pioneer Hi-Bred International, Inc. Cas9 orthologs
AU2019255725A1 (en) * 2018-04-18 2020-12-10 Ligandal, Inc. Methods and compositions for genome editing
US11518999B1 (en) 2018-11-09 2022-12-06 Inari Agriculture Technology, Inc. Plant transformation
WO2020123887A2 (en) 2018-12-14 2020-06-18 Pioneer Hi-Bred International, Inc. Novel crispr-cas systems for genome editing
CN111363013B (zh) * 2018-12-25 2021-11-19 深圳先进技术研究院 多组分纳米颗粒簇的构建方法
US11692197B2 (en) 2019-05-06 2023-07-04 Inari Agriculture Technology, Inc. Delivery of biological molecules to plant cells
WO2020264016A1 (en) 2019-06-25 2020-12-30 Inari Agriculture, Inc. Improved homology dependent repair genome editing
AU2021312243A1 (en) 2020-07-20 2023-02-23 Flagship Pioneering Innovations Vii, Llc Viroid-derived polynucleotides for modification of plants
US20220040315A1 (en) * 2020-08-09 2022-02-10 Fulu Labs Corporation Nuclease-dendrimer formulations for covid-19 and broad-spectrum antiviral therapy and prophylaxis
UY39997A (es) 2021-11-01 2023-05-15 Flagship Pioneering Innovations Vii Llc Polinucleótidos para modificar organismos
IL314307A (en) 2022-01-20 2024-09-01 Flagship Pioneering Innovations Vii Llc Polynucleotides for modifying organisms
EP4299739A1 (en) 2022-06-30 2024-01-03 Inari Agriculture Technology, Inc. Compositions, systems, and methods for genome editing
EP4299733A1 (en) 2022-06-30 2024-01-03 Inari Agriculture Technology, Inc. Compositions, systems, and methods for genome editing
WO2024005863A1 (en) 2022-06-30 2024-01-04 Inari Agriculture Technology, Inc. Compositions, systems, and methods for genome editing
WO2024005864A1 (en) 2022-06-30 2024-01-04 Inari Agriculture Technology, Inc. Compositions, systems, and methods for genome editing
WO2024229398A1 (en) 2023-05-03 2024-11-07 Flagship Pioneering Innovations Vii, Llc Artificial amalgavirus satellite rnas
AR132591A1 (es) 2023-05-03 2025-07-16 Flagship Pioneering Innovations Vii Llc Arn satélite de secoviridae artificiales
WO2024229395A1 (en) 2023-05-03 2024-11-07 Flagship Pioneering Innovations Vii, Llc Partitiviral satellite rna amplification systems for plants
AR132587A1 (es) 2023-05-03 2025-07-16 Flagship Pioneering Innovations Vii Llc Arn satélite de martellivirales artificiales
AR133211A1 (es) 2023-05-03 2025-09-10 Flagship Pioneering Innovations Vii Llc Arn satélite artificiales de tombusviridae
AR132589A1 (es) 2023-05-03 2025-07-16 Flagship Pioneering Innovations Vii Llc Arn satélite de solemoviridae artificiales
WO2024229385A1 (en) 2023-05-03 2024-11-07 Flagship Pioneering Innovations Vii, Llc Artificial ghabrivirales satellite rnas
AR132585A1 (es) 2023-05-03 2025-07-16 Flagship Pioneering Innovations Vii Llc Sistemas de amplificación de arn satélite endornavirales para plantas
AR132588A1 (es) 2023-05-03 2025-07-16 Flagship Pioneering Innovations Vii Llc Arn satélite de tymovirales artificiales
WO2025076141A1 (en) 2023-10-03 2025-04-10 Inari Agriculture Technology, Inc. Viral delivery of grna to the scion

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050059031A1 (en) * 2000-10-06 2005-03-17 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes
DE10254166A1 (de) * 2002-11-20 2004-06-03 Icon Genetics Ag Verfahren zur Kontrolle eines zellulären Prozesses in Pflanzen
MXPA06000092A (es) 2003-07-01 2006-04-07 Biolex Inc Transformacion de cloroplasto de la lenteja de agua.
CN1687427A (zh) * 2005-03-30 2005-10-26 湖南大学 基于超声波介导的纳米颗粒作载体的基因转导方法
MX2007010402A (es) * 2005-04-20 2008-01-22 Dendritic Nanotechnologies Inc Polimeros dendriticos con amplificacion mejorada y funcionalidad interior.
US20070016985A1 (en) * 2005-07-18 2007-01-18 Pioneer Hi-Bred International, Inc. Particle Preparation for Direct-Delivery Transformation
KR100821192B1 (ko) * 2005-09-08 2008-04-11 주식회사바이테리얼즈 형광성을 가지는 자성 나노 입자 및 그 제조방법
CA2621352A1 (en) 2005-09-08 2007-03-15 Biterials Co., Ltd. Magnetic nanoparticle having fluorescent and preparation method thereof and use thereof
WO2007050715A2 (en) * 2005-10-26 2007-05-03 Integrated Plant Genetics, Inc. Compositions and methods for safe delivery of biologically-active plant transformation agents using non-fibrous silicon carbide powder
ES2776100T3 (es) * 2006-03-31 2020-07-29 Massachusetts Inst Technology Sistema para el suministro dirigido de agentes terapéuticos
US9428756B2 (en) * 2006-08-11 2016-08-30 Dow Agrosciences Llc Zinc finger nuclease-mediated homologous recombination
JP5507459B2 (ja) * 2007-10-05 2014-05-28 ダウ アグロサイエンシィズ エルエルシー 植物細胞に分子性物質を移行させる方法

Also Published As

Publication number Publication date
BRPI1015952B1 (pt) 2018-12-04
US20170022521A1 (en) 2017-01-26
RU2017104660A (ru) 2018-08-15
JP2015171370A (ja) 2015-10-01
WO2010118077A1 (en) 2010-10-14
BRPI1015952B8 (pt) 2022-06-28
EP2417262A1 (en) 2012-02-15
JP5755636B2 (ja) 2015-07-29
TW201040277A (en) 2010-11-16
RU2612156C2 (ru) 2017-03-02
TWI576432B (zh) 2017-04-01
JP6513127B2 (ja) 2019-05-15
IL214880A (en) 2016-04-21
AU2010234539A1 (en) 2011-09-15
US9719108B2 (en) 2017-08-01
CA2757831A1 (en) 2010-10-14
CN102369287A (zh) 2012-03-07
HUE026053T2 (en) 2016-05-30
RU2015120061A (ru) 2015-10-20
CN102369287B (zh) 2014-09-17
BRPI1015952A2 (pt) 2015-09-01
ES2539327T3 (es) 2015-06-29
US20100311168A1 (en) 2010-12-09
RU2017104660A3 (da) 2018-08-15
RU2556376C2 (ru) 2015-07-10
SI2417262T1 (sl) 2015-08-31
AU2010234539B2 (en) 2015-04-09
KR101701534B1 (ko) 2017-02-01
US9187755B2 (en) 2015-11-17
KR20120003933A (ko) 2012-01-11
AR076225A1 (es) 2011-05-26
HRP20150564T1 (hr) 2015-08-28
JP2017200479A (ja) 2017-11-09
RU2011144872A (ru) 2013-05-20
JP2012523234A (ja) 2012-10-04
JP6275668B2 (ja) 2018-02-07
CA2757831C (en) 2017-09-26
ZA201106262B (en) 2012-10-31
PT2417262E (pt) 2015-07-23
RU2664865C2 (ru) 2018-08-23
EP2417262B1 (en) 2015-05-20
IL214880A0 (en) 2011-11-30

Similar Documents

Publication Publication Date Title
DK2417262T3 (da) Nanopartikelmedieret tilførsel af sekvensspecifikke nukleaser
DK3175863T3 (da) Varianter af c-type natriuretisk peptid
SMT201400030B (it) Profarmaci del dolutegravir
SMT201600075B (it) Composto di diamminocarbossammide eterociclica
DK2386171T3 (da) Tilpasning af overgivelsesparametre
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
DK2271642T3 (da) Pyridylinhibitorer af hedgehog signalering
BR112012001325A2 (pt) tratamento de distúrbios do fígado com inibidaores de pi3k
DK2498756T3 (da) Tabletformuleringer af neratinibmaleat
DK2318396T5 (da) Krystalform af posaconazol
PT2414890T (pt) Fabricação de dispositivos electrocrómicos de baixa defetividade
BRPI1015034A2 (pt) artigo absorvente descartável
HRP20180429T1 (hr) Raspršivač
DK2459129T3 (da) Forbedringer af karstøtteanordninger
DK2603232T3 (da) Stabile formuleringer af linaclotid
EP2399504A4 (en) DEVICE FOR INTRODUCING ENDOSCOPE
PL2493466T3 (pl) Nowe przeciwguzowe zastosowanie kabazytakselu
UY33155A (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
BR112012005016A2 (pt) artigo absorvente
DK2411009T3 (da) Terapeutiske anvendelser af quinazolindionderivater
DK2252317T3 (da) Behandling af makuladegeneration
BRPI1008299A2 (pt) artigo absorvente
BR112012005382A2 (pt) inibidores de jak
DK2506840T3 (da) Anvendelser af hæmmere af hypoksi-fremkaldende faktorer